blog

As originally conceived, personalized medicine referred to the tailoring of medical treatment to the individual characteristics of each patient. The right drug for the right patient at the right timehas since evolved to an approach that takes into account individual differences in people’s genes, environments, and lifestyles. 

Topics: Patient Experience, Pharma15 Live!, Vlog, Precision Medicine, Precision Support

While most large pharma companies seem “very open” to new technologies, a recent FiercePharma article also notes that the life science industry hasn’t exactly won accolades for its speed in adopting new artificial intelligence and machine learning technologies. However, since patient lives are at stake, the industry has good reason to proceed with caution.*

Dena Raffa, Director, Account Operations and BBK’s expert in digital innovation, shares her view on the complex topic of AI and machine learning technologies in life sciences. 

Topics: Disruptive Innovation, Trends, AI, Pharma15 Live!, Vlog

A recent survey shared in FiercePharma pointed to an upward trend in general public opinion of the pharmaceutical industry. But there is still work to be done.* 

Rob Laurens, Principal, Human Resources and Quality Assurance, credits much of this momentum to the work of everyone in the clinical R&D sector. 

Topics: Clinical Research, Big Data, Patient Experience, Pharma15 Live!, Vlog, Privacy

The idea of “digital patient engagement” continues to be one of the hottest topics in the healthcare industry, and according to BBK Worldwide director of innovation Erica Mercado, everyone defines this term in different ways. For instance, apps, wearables, and digital outreach and messaging are all tactics that can be effectively deployed to keep patients engaged. But for Erica, truly effective digital patient engagement amounts to more than the sum of its parts.

Topics: Patient Engagement, Digital Health, Patient Experience, Pharma15 Live!, Vlog

There is no doubt that Amazon’s recent acquisition of PillPack – the independent pharmacy and medication distribution system – has major implications not only for the clinical research industry, but the healthcare industry at-large. We asked BBK Worldwide president Matt Kibby to weigh in on Amazon’s foray into the pharmaceutical space. 

Topics: Pharma15 Live!, Vlog